Wednesday, 23 September 2015

Drug-gouging debate isn’t CEO’s first controversy

Drug-gouging debate isn’t CEO’s first controversy

The pharmaceutical company boss under fire from Hillary Clinton and many others for jacking up the price of the drug Daraprim 5,500 percent overnight allegedly engaged previously in a bizarre campaign of "harassment" of a former employee and his immediate family, according to court documents. Drug boss Martin Shkreli, 32, also allegedly gained access to social media accounts belonging to that ex-employee...
Read more: http://ift.tt/1FtiNM7

No comments:

Post a Comment